Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2018-01-31 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
独立董事关于2017年度日常关联交易总金额差异情况的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent director's opinion on the company's 2017 annual related party transactions, discussing the actual versus expected transaction amounts and their impact on the company. It references regulatory guidelines and company bylaws but does not contain financial statements or detailed financial data. The document is relatively short (879 characters) and serves as a formal opinion or statement rather than a full report. It does not fit categories like Annual Report, Interim Report, or Audit Report. It is also not a voting result, management change, or earnings release. The content aligns best with a Regulatory Filing (RNS) as it is a compliance-related disclosure about related party transactions and independent director opinions without substantive financial data or report format.
2018-01-31 Chinese
关于对全资子公司增资的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the capital increase (增资) in several wholly-owned subsidiaries of the company. It details the amounts, purposes, and financial data of the subsidiaries involved. The document includes board approval information and states that the capital increase requires shareholder approval. There is no indication that this is a full financial report, audit report, or earnings release. Instead, it is a corporate announcement about financing activities related to capital structure changes within subsidiaries. This fits the definition of a Capital/Financing Update (CAP). The document length is about 5,399 characters, which is sufficient for a detailed announcement rather than a brief notice or report publication announcement. Therefore, the classification is CAP with high confidence.
2018-01-31 Chinese
关于变更会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of the company's auditor (accounting firm) for the 2017 fiscal year. It details the decision made by the board of directors, the reasons for the change, the new auditor's qualifications, and the procedural steps taken including independent directors' opinions and the need for shareholder approval. The document does not contain any financial statements or audit reports themselves, but rather informs stakeholders about the auditor change. The document length is 2121 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this is not an Audit Report (AR) but an announcement about auditor change, which fits best under Regulatory Filings (RNS) as it is a regulatory announcement that does not fit other specific categories.
2018-01-31 Chinese
第八届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 7th meeting of the 8th Board of Directors of the company. It includes approvals of various internal governance rules, capital increases in subsidiaries, change of auditor, and plans for an upcoming extraordinary general meeting. The content focuses on board decisions and governance matters rather than financial results or audit reports. It is not a full annual or interim report, nor an earnings release. The document is a formal board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is over 6000 characters and contains substantive content, not just a brief announcement or notice, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the best classification is MANG with high confidence.
2018-01-31 Chinese
总经理工作细则（2018年1月）
Governance Information Classification · 95% confidence The document is titled '总经理工作细则' which translates to 'General Manager Work Rules' or 'General Manager Operating Procedures'. It details the responsibilities, authority, meeting procedures, reporting requirements, and performance evaluation mechanisms for the company's general manager and other senior management personnel. It references company governance structure, legal compliance, and internal management rules. There is no indication that this is a financial report, audit, earnings release, or any regulatory filing related to financial results or shareholder meetings. Instead, it is a governance-related document focusing on management roles and internal rules. Therefore, the document fits best under the category of Governance Information (CGR). The document length (9099 characters) and content confirm it is a substantive governance report, not a brief announcement or certification.
2018-01-31 Chinese
董事会提名委员会工作细则（2018年1月）
Governance Information Classification · 95% confidence The document is titled as the 'Board Nomination Committee Working Rules' of the company, detailing the structure, responsibilities, procedures, and rules of the board nomination committee. It focuses on governance practices related to board and senior management nominations, committee composition, meeting rules, and decision-making processes. There is no financial data, earnings information, or regulatory filing content. The document is a governance-related internal rules report rather than an announcement, report, or certification. Therefore, it fits best under Governance Information (CGR). The document length is 2340 characters, which is relatively short but contains substantive governance content, not just an announcement or summary.
2018-01-31 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.